[HTML][HTML] A comprehensive review on novel liposomal methodologies, commercial formulations, clinical trials and patents

VVSNL Andra, SVN Pammi, LVKP Bhatraju… - Bionanoscience, 2022 - Springer
Liposomes are well-recognized and essential nano-sized drug delivery systems. Liposomes
are phospholipid vesicles comprised of cell membrane components and have been …

Liposomes: a review of manufacturing techniques and targeting strategies

B Maherani, E Arab-Tehrany, MR Mozafari… - Current …, 2011 - ingentaconnect.com
Today, liposomes are among the most applied technologies for the encapsulation and
delivery of bioactive agents and many different compounds in biological, pharmaceutical …

[HTML][HTML] Progress towards in vivo use of siRNAs

MA Behlke - Molecular Therapy, 2006 - cell.com
RNA interference (RNAi) has become the method of choice to suppress gene expression in
vitro. It is also emerging as a powerful tool for in vivo research with over 90 studies …

Signaling danger: toll-like receptors and their potential roles in kidney disease

HJ Anders, B Banas, D Schlöndorff - Journal of the American …, 2004 - journals.lww.com
Toll-like receptors (TLR) are an emerging family of receptors that recognize pathogen-
associated molecular patterns and promote the activation of leukocytes and intrinsic renal …

Novel antisense and peptide nucleic acid strategies for controlling gene expression

DA Braasch, DR Corey - Biochemistry, 2002 - ACS Publications
Antisense oligonucleotides have the potential to make revolutionary contributions to basic
science and medicine. Oligonucleotides can bind mRNA and inhibit translation. Because …

Complement-induced cell death by rituximab depends on CD20 expression level and acts complementary to antibody-dependent cellular cytotoxicity

T van Meerten, RS van Rijn, S Hol, A Hagenbeek… - Clinical cancer …, 2006 - AACR
Purpose: The use of the CD20-specific antibody rituximab has greatly improved the
response to treatment of CD20+ follicular lymphoma. Despite the success of rituximab …

Calcein release behavior from liposomal bilayer; influence of physicochemical/mechanical/structural properties of lipids

B Maherani, E Arab-Tehrany, A Kheirolomoom, D Geny… - Biochimie, 2013 - Elsevier
The design of the drug delivery depends upon different parameters. One of the most
noticeable factors in design of the drug delivery is drug-release profile which determines the …

CpG oligodeoxynucleotides as vaccine adjuvants in primates

D Verthelyi, RT Kenney, RA Seder, AA Gam… - The journal of …, 2002 - journals.aai.org
Synthetic oligodeoxynucleotides (ODN) containing unmethylated CpG motifs act as immune
adjuvants in mice, boosting the humoral and cellular response to coadministered Ags. CpG …

Contrasting activity of cytosin–guanosin dinucleotide oligonucleotides in mice with experimental colitis

F Obermeier, N Dunger, UG Strauch… - Clinical & …, 2003 - academic.oup.com
Intestinal inflammation in inflammatory bowel disease (IBD) and experimental models of
colitis is characterized by a dysregulated intestinal immune response with elevated levels of …

Treatment of established asthma in a murine model using CpG oligodeoxynucleotides

JN Kline, K Kitagaki, TR Businga… - American Journal of …, 2002 - journals.physiology.org
Allergen immunotherapy is an effective but underutilized treatment for atopic asthma. We
have previously demonstrated that CpG oligodeoxynucleotides (CpG ODN) can prevent the …